Company logo

SCYX - SCYNEXIS, Inc.

NASDAQ -> Healthcare -> Drug Manufacturers—Specialty & Generic
Jersey City, United States
Type: Equity

SCYX price evolution
SCYX
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Jan 2023
Current assets
Cash $44.62 $58.5 $27.13 $46.03
Short term investments $44 $27.64 $27.91 $27.69
Net receivables $23.9 $46.59 $2.06 $2.1
Inventory $13.11 $10.29 $1.1 $0.9
Total current assets $128.64 $145.53 $59.77 $79.06
Long term investments $17.11 $6.34
Property, plant & equipment $2.42 $2.48 $2.54 $2.59
Goodwill & intangible assets $0.1 $0.21 $0.31 $0.41
Total noncurrent assets $19.91 $9.33 $10.53 $8.75
Total investments $61.12 $33.97 $27.91 $27.69
Total assets $148.55 $154.86 $70.3 $87.81
Current liabilities
Accounts payable $3.49 $3.42 $5.92 $5.94
Deferred revenue $4.08 $4.37
Short long term debt $0.33 $0.31 $34.94 $0.28
Total current liabilities $16.79 $16.16 $45.64 $17.62
Long term debt $14.48 $14.39 $14.25 $45.39
Total noncurrent liabilities $39.77 $45.62 $54.57 $66.96
Total debt $14.81 $14.7 $49.19 $48.6
Total liabilities $56.55 $61.78 $100.21 $84.58
Shareholders' equity
Retained earnings -$335.66 -$333.9 -$456.16 -$422.29
Other shareholder equity
Total shareholder equity $91.99 $93.08 -$29.91 $3.23
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $46.03 $104.7 $93.31 $42.19
Short term investments $27.69 $6.49
Net receivables $2.1 $0.86 $2.9
Inventory $0.9 $0.46
Total current assets $79.06 $109.38 $98.21 $52.4
Long term investments
Property, plant & equipment $2.59 $2.91 $3.3 $3.6
Goodwill & intangible assets $0.41 $1.06
Total noncurrent assets $8.75 $10.46 $4.33 $4.75
Total investments $27.69 $6.49
Total assets $87.81 $119.84 $102.54 $57.15
Current liabilities
Accounts payable $5.94 $7.85 $4.64 $7.18
Deferred revenue
Short long term debt $0.28 $0.07 $0.05 $0.04
Total current liabilities $17.62 $13.62 $26.4 $11.01
Long term debt $45.39 $43.56 $19.79 $14.85
Total noncurrent liabilities $66.96 $64.96 $53.38 $33.24
Total debt $48.6 $43.63 $19.84 $14.88
Total liabilities $84.58 $78.58 $79.78 $44.26
Shareholders' equity
Retained earnings -$422.29 -$359.48 -$326.61 -$271.43
Other shareholder equity
Total shareholder equity $3.23 $41.26 $22.76 $12.89
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Revenue
Total revenue $1.76 $131.45 $1.13 $1.52
Cost of revenue $0.38 $0.43 $0.14 $0.2
Gross Profit $1.38 $131.03 $0.99 $1.33
Operating activities
Research & development $6.47 $7.04 $6.83 $7.85
Selling, general & administrative $5.01 $7.47 $4.84 $15.96
Total operating expenses $11.48 $14.51 $11.68 $23.81
Operating income -$10.1 $116.51 -$10.68 -$22.48
Income from continuing operations
EBIT -$1.54 $123.51 -$32.43 -$12.9
Income tax expense
Interest expense $0.21 $1.25 $1.45 $1.53
Net income
Net income -$1.76 $122.26 -$33.88 -$14.43
Income (for common shares) -$1.76 $122.26 -$33.88 -$14.43
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $5.09 $13.16 $0.12
Cost of revenue $0.63 $0.31
Gross Profit $4.46 $12.85 $0.12
Operating activities
Research & development $27.26 $23.77 $36.52 $38.39
Selling, general & administrative $62.96 $49.92 $14.63 $10.65
Total operating expenses $90.22 $73.69 $51.15 $49.04
Operating income -$85.76 -$60.84 -$51.15 -$48.92
Income from continuing operations
EBIT -$62.31 -$33.29 -$57.15 -$52.72
Income tax expense -$4.7 -$3.09 -$3.15
Interest expense $5.2 $2.66 $1.18 $0.99
Net income
Net income -$62.81 -$32.87 -$55.19 -$53.71
Income (for common shares) -$62.81 -$32.87 -$55.19 -$53.71
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$1.76 $122.26 -$33.88 -$14.43
Operating activities
Depreciation $0.15 $0.15 $0.15 $0.15
Business acquisitions & disposals
Stock-based compensation $0.63 $0.73 $0.71 $0.45
Total cash flows from operations $12.42 $74.4 -$18.92 -$22.81
Investing activities
Capital expenditures
Investments -$26.34 -$6.38
Total cash flows from investing -$26.34 -$6.38
Financing activities
Dividends paid
Sale and purchase of stock $0.03 $0 $0.02
Net borrowings -$36.65
Total cash flows from financing $0.03 -$36.64 $0.02
Effect of exchange rate
Change in cash and equivalents -$13.89 $31.37 -$18.9 -$22.81
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$62.81 -$32.87 -$55.19 -$53.71
Operating activities
Depreciation $0.61 $0.38 $0.11 $0.11
Business acquisitions & disposals
Stock-based compensation $3.69 $2.09 $2.22 $1.83
Total cash flows from operations -$79.88 -$54.56 -$49.35 -$38.12
Investing activities
Capital expenditures -$0
Investments -$27.38 $6.48 $26.24
Total cash flows from investing -$27.39 -$1.17 $6.47 $26.24
Financing activities
Dividends paid
Sale and purchase of stock $47.27 $38.58 $90.37 $46.39
Net borrowings $4.97 $28.75 $9.51 -$1.23
Total cash flows from financing $48.6 $67.12 $94 $42.3
Effect of exchange rate
Change in cash and equivalents -$58.67 $11.39 $51.12 $30.43
Fundamentals
Market cap $54.68M
Enterprise value $24.88M
Shares outstanding 37.20M
Revenue $135.87M
EBITDA $77.24M
EBIT $76.64M
Net Income $72.20M
Revenue Q/Q 13.10%
Revenue Y/Y 3.16K%
P/E ratio 0.76
EV/Sales 0.18
EV/EBITDA 0.32
EV/EBIT 0.32
P/S ratio 0.40
P/B ratio 0.59
Book/Share 2.47
Cash/Share 1.20
EPS $1.94
ROA 62.58%
ROE 182.33%
Debt/Equity 26.16
Net debt/EBITDA 0.15
Current ratio 7.66
Quick ratio 6.88